GcMAF 2.5ml high dose multi-dose vials (1500ng/0.5ml) for MAF therapy

What are GcMAF 2.5ml high dose multi-dose vials (1500 ng/0.5 ml) for MAF therapy?

GcMAF (Gc protein-derived macrophage activating factor) is a protein produced by protein naturally promoted by lymphocytes. It works as macrophage-activating factor, sending signal to macrophages to attack the tumor cells, pathogens and cytokine secretions without causing the inflammation within the body. Mirai Saisei, once a small venture biotechnological company based on Tokushima University laboratory, is now a net of clinics specializing on innovative treatment of cancer with GcMAF therapy. This medicine is a high-concentrated multi-dose GcMAF solution for intravenous or subcutaneous injection.

According to maker’s clinical researches these medicines are effective for the following symptoms:

• Treatment of cancer of varying severity (stages 1 to 4).
• Treatment of chronic infectious diseases such as Hepatitis C and B.
• Treatment of multiple sclerosis, its neurological symptoms and the achievement of sustained remission.
• Treatment of chronic fatigue symptoms (period of intense fatigue of 6 months or more).
• Treatment of symptoms of rheumatoid arthritis and its prevention at early stages.
• Treatment of child autism.

This medicine is safe, well-tolerated with almost no side effects. It's 100% gluten-free, soy bean free and allergen free.

Shipping

Please pay attention when choosing a delivery form, the drug can be sent only by EMS in special safe-pack with temperature support. We cannot send it via sea mail. Upon arrival, you should immediately receive the parcel and put the preparation in the refrigerator. It should be used as quickly as possible, within 2-4 weeks. If you need to store the medicine longer – please put it inside the freezer. Warm to room temperature before use and move the bottle to fridge.

Payment 

Payment for this prescription medicine is accepted only by bank due to local Japanese drug law regulations of oncology medicines. Price is indicated on this page and is not subject to any other discounts.

Brand name: name was changed by maker to M Protein from 2020. The active ingredient and maker are the same as before. 

Active principles: GcMAF

Amount: 1 bottle * 2.5 ml

Maker: Saisei Pharma Co., Ltd., Osaka, Japan

How to use

For cancer treatment, apply intramuscularly or subcutaneously as close as possible to the affected area (both tumour and metastasis). For maximum effect, this medicine should be combined with traditional oral medications, following the guidelines for their use. The dosage of GcMAF depends on the stage of progress of cancer.

• 1 stage: 0.5 ml 1-2 times a week.
• 2 stage: 0.5 ml 1-2 times a week.
• 3 stage: 0.5 ml 2-4 times a week or 1 ml 1-3 times a week.
• 4 stage: 0.5 ml every day.

Important information

If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.

GcMAF 2.5ml high dose multi-dose vials (1500ng/0.5ml) for MAF therapy

Features of oncology treatment using MAF medicines.

Preparations of the third generation of MAF have undergone clinical trials and are effective not only for general immunotherapy, but also for the treatment of cancer. The greatest effect is manifested when using the specialized GcMAF protein for treatment.